The RAS-MAPK kinase pathway is one of the signaling cascades activated by ERBB2 and is suggested to be in concert with the PI3K/AKT pathway in ERBB2-positive breast cancer [10, 11]. The gene discussed is AKT1; the disease is breast carcinoma.